![Cancers | Free Full-Text | Diagnostic Performance of Risk of Malignancy Algorithm (ROMA), Risk of Malignancy Index (RMI) and Expert Ultrasound Assessment in a Pelvic Mass Classified as Inconclusive by International Ovarian Cancers | Free Full-Text | Diagnostic Performance of Risk of Malignancy Algorithm (ROMA), Risk of Malignancy Index (RMI) and Expert Ultrasound Assessment in a Pelvic Mass Classified as Inconclusive by International Ovarian](https://pub.mdpi-res.com/cancers/cancers-14-00810/article_deploy/html/images/cancers-14-00810-g001-550.jpg?1644399702)
Cancers | Free Full-Text | Diagnostic Performance of Risk of Malignancy Algorithm (ROMA), Risk of Malignancy Index (RMI) and Expert Ultrasound Assessment in a Pelvic Mass Classified as Inconclusive by International Ovarian
![RMI and ROMA are equally effective in discriminating between benign and malignant gynecological tumors: A prospective population‐based study - Liest - 2019 - Acta Obstetricia et Gynecologica Scandinavica - Wiley Online Library RMI and ROMA are equally effective in discriminating between benign and malignant gynecological tumors: A prospective population‐based study - Liest - 2019 - Acta Obstetricia et Gynecologica Scandinavica - Wiley Online Library](https://obgyn.onlinelibrary.wiley.com/cms/asset/f0f6948d-6e42-4d4e-81db-9ecdebefe633/aogs13462-fig-0001-m.jpg)
RMI and ROMA are equally effective in discriminating between benign and malignant gynecological tumors: A prospective population‐based study - Liest - 2019 - Acta Obstetricia et Gynecologica Scandinavica - Wiley Online Library
![Comparison of Risk of Ovarian Malignancy Algorithm and cancer antigen 125 to discriminate between benign ovarian tumor and early‑stage ovarian cancer according to imaging tumor subtypes Comparison of Risk of Ovarian Malignancy Algorithm and cancer antigen 125 to discriminate between benign ovarian tumor and early‑stage ovarian cancer according to imaging tumor subtypes](https://www.spandidos-publications.com/article_images/ol/20/1/ol-20-01-0931-g00.jpg)
Comparison of Risk of Ovarian Malignancy Algorithm and cancer antigen 125 to discriminate between benign ovarian tumor and early‑stage ovarian cancer according to imaging tumor subtypes
![Modified HE4, CA125, and ROMA cut-off values and predicted probability of ovarian tumor in Chinese patients - Zhao - Gland Surgery Modified HE4, CA125, and ROMA cut-off values and predicted probability of ovarian tumor in Chinese patients - Zhao - Gland Surgery](https://cdn.amegroups.cn/journals/amepc/files/journals/11/articles/83393/public/83393-PB7-2189-R1.jpg/w300)
Modified HE4, CA125, and ROMA cut-off values and predicted probability of ovarian tumor in Chinese patients - Zhao - Gland Surgery
![Frontiers | Copenhagen index (CPH-I) is more favorable than CA125, HE4, and risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models with clinical-ultrasonographic feature for diagnosing ovarian neoplasms Frontiers | Copenhagen index (CPH-I) is more favorable than CA125, HE4, and risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models with clinical-ultrasonographic feature for diagnosing ovarian neoplasms](https://www.frontiersin.org/files/MyHome%20Article%20Library/1068492/1068492_Thumb_400.jpg)
Frontiers | Copenhagen index (CPH-I) is more favorable than CA125, HE4, and risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models with clinical-ultrasonographic feature for diagnosing ovarian neoplasms
![Cancers | Free Full-Text | The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population Cancers | Free Full-Text | The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population](https://www.mdpi.com/cancers/cancers-14-02124/article_deploy/html/images/cancers-14-02124-g001.png)
Cancers | Free Full-Text | The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population
![Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer | Scientific Reports Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-59009-z/MediaObjects/41598_2020_59009_Fig3_HTML.png)
Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer | Scientific Reports
![C- 1 A New Test for Assessing the Risk of Ovarian Cancer in Women with Adnexal Mass Presenter Place Date. - ppt download C- 1 A New Test for Assessing the Risk of Ovarian Cancer in Women with Adnexal Mass Presenter Place Date. - ppt download](https://images.slideplayer.com/12/3592930/slides/slide_41.jpg)
C- 1 A New Test for Assessing the Risk of Ovarian Cancer in Women with Adnexal Mass Presenter Place Date. - ppt download
![Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis | Scientific Reports Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-96552-9/MediaObjects/41598_2021_96552_Fig8_HTML.png)
Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis | Scientific Reports
![Diagnostic performance of CA125, HE4, ROMA, and CPH‐I in identifying primary ovarian cancer - Luo - 2023 - Journal of Obstetrics and Gynaecology Research - Wiley Online Library Diagnostic performance of CA125, HE4, ROMA, and CPH‐I in identifying primary ovarian cancer - Luo - 2023 - Journal of Obstetrics and Gynaecology Research - Wiley Online Library](https://obgyn.onlinelibrary.wiley.com/cms/asset/ed72631c-640e-4a00-81b6-93be25472d90/jog.v49.3.cover.jpg)
Diagnostic performance of CA125, HE4, ROMA, and CPH‐I in identifying primary ovarian cancer - Luo - 2023 - Journal of Obstetrics and Gynaecology Research - Wiley Online Library
![SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian](https://minio.scielo.br/documentstore/1980-5322/33NknbMHmXvr6ysnZjDL7Vd/7240101f361005f36d10165d48e3ababed511b16.jpg)
SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian
![Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis | Scientific Reports Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-96552-9/MediaObjects/41598_2021_96552_Fig1_HTML.png)
Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis | Scientific Reports
![Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis | Scientific Reports Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-96552-9/MediaObjects/41598_2021_96552_Fig4_HTML.png)